Search Results - "Ralser, D.J."

1480P Integrating the on-treatment mGPS improves prognostic accuracy of imaging-based staging in patients with non-small-cell lung cancer (NSCLC) treated with immune-checkpoint inhibitors by Saal, J., Bald, T., Eckstein, M., Ralser, D.J., Brossart, P., Ellinger, J., Hölzel, M., Klümper, N.

Get full text

On-treatment modified Glasgow prognostic score (mGPS) improves imaging-only prediction of response and outcomes in metastatic renal cell carcinoma by Saal, J., Bald, T., Eckstein, M., Ralser, D.J., Ritter, M., Brossart, P., Grünwald, V., Hölzel, M., Ellinger, J., Klümper, N.

Get full text

A0332 - On-treatment modified Glasgow prognostic score (mGPS) improves imaging-only prediction of response and outcomes in metastatic renal cell carcinoma by Saal, J., Bald, T., Eckstein, M., Ralser, D.J., Ritter, M., Brossart, P., Grünwald, V., Hölzel, M., Ellinger, J., Klümper, N.

Get full text

A0539 - Preclinical evidence for the use of anti-TROP-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer by Weiten, R., Niemann, M., Below, E., Friker, L.L., Ralser, D.J., Toma, M., Kristiansen, G., Hahn, O., Zechel, S., Grünwald, V., Bald, T., Siewert, J., Pietsch, T., Ritter, M., Hölzel, M., Eckstein, M., Alajati, A., Krausewitz, P., Klümper, N.

Get full text

Preclinical evidence for the use of anti-TROP-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer by Weiten, R., Niemann, M., Below, E., Friker, L.L., Ralser, D.J., Toma, M., Kristiansen, G., Hahn, O., Zechel, S., Grünwald, V., Bald, T., Siewert, J., Pietsch, T., Ritter, M., Hölzel, M., Eckstein, M., Alajati, A., Krausewitz, P., Klümper, N.

Get full text

Identification of a founder mutation in KRT 14 associated with Naegeli–Franceschetti–Jadassohn syndrome by Ralser, D.J., Kumar, S., Borisov, O., Sarig, O., Richard, G., Wolf, S., Krawitz, P.M., Sprecher, E., Kreiß, M., Betz, R.C.

Get full text

Loss of membranous NECTIN-4 occurs frequently during metastatic spread of urothelial carcinoma and predicts resistance to enfortumab vedotin by Klümper, N., Ralser, D.J., Ellinger, J., Roghmann, F., Breyer, J., Bolenz, C., Zengerling, F., Erben, P., Schwamborn, K., Horn, T., Kristiansen, G., Grünwald, V., Darr, C., Rausch, S., Schlack, K., Zschäbitz, S., Wullich, B., Ritter, M., Hartmann, A., Gschwend, J.E., Weichert, W., Erlmeier, F., Hölzel, M., Eckstein, M.

Get full text

A0541 - Loss of membranous NECTIN-4 occurs frequently during metastatic spread of urothelial carcinoma and predicts resistance to enfortumab vedotin by Klümper, N., Ralser, D.J., Ellinger, J., Roghmann, F., Breyer, J., Bolenz, C., Zengerling, F., Erben, P., Schwamborn, K., Horn, T., Kristiansen, G., Grünwald, V., Darr, C., Rausch, S., Schlack, K., Zschäbitz, S., Wullich, B., Ritter, M., Hartmann, A., Gschwend, J.E., Weichert, W., Erlmeier, F., Hölzel, M., Eckstein, M.

Get full text

PDCD1 methylation predicts response to anti–PD-1 based immunotherapy in advanced and metastatic renal cell carcinoma by Klümper, N., Ralser, D.J., Zarbl, R., Schlack, K., Schrader, A.J., Rehlinghaus, M., Hoffmann, M.J., Niegisch, G., Uhlig, A., Trojan, L., Steinestel, J., Steinestel, K., Wirtz, R.M., Kristiansen, G., Toma, M., Hölzel, M., Ritter, M., Strieth, S., Ellinger, J., Dietrich, D.

Get full text

Identification of a founder mutation in KRT14 associated with Naegeli–Franceschetti–Jadassohn syndrome by Ralser, D.J., Kumar, S., Borisov, O., Sarig, O., Richard, G., Wolf, S., Krawitz, P.M., Sprecher, E., Kreiß, M., Betz, R.C.

Get full text

Mast cell activation in Dowling–Degos disease by Knuever, J., Persa, O.D., Illerhaus, A., Ralser, D.J., Hartmann, K., Betz, R.C., Tantcheva‐poór, I.

Get full text

Functional implications of novel ADAM10 mutations in reticulate acropigmentation of Kitamura by Ralser, D.J., Lestringant, G.G., Du‐Thanh, A., Kokordelis, P., Fischer, J., Basmanav, F.B.Ünalan, Wolf, S., Thiele, H., Altmüller, J., Nürnberg, P., Oji, V., Fritz, G., Frank, J., Betz, R.C.

Get full text